| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/05/1997 | CN1141739A Health-care salt |
| 02/05/1997 | CN1033976C Preparation of polypeptides used as blockers of calcium channels |
| 02/04/1997 | US5599972 Aminobenzoic acid derivatives |
| 02/04/1997 | US5599941 Treatment of intestinal motility disorders |
| 02/04/1997 | US5599937 Heteroaromatic quinuclidinenes, their use and preparation |
| 02/04/1997 | US5599812 Tricyclic pyrrolopyrazine 5-HT3 -active compounds |
| 02/04/1997 | US5599810 Furo- and thieno[4,3,2-ef][3]benzazepines useful as alpha adrenergic receptor antagonists |
| 02/04/1997 | US5599794 Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic |
| 02/04/1997 | US5599559 Calcium channel blocking polypeptide from agelenopsis aperta and therapeutic methods employing it |
| 02/04/1997 | CA2053820C Method of inhibiting metabolism of cholesterol |
| 02/04/1997 | CA2006703C Antibacterial anti-plaque oral composition |
| 01/30/1997 | WO1997003211A1 Antisense inhibition of hepatitis b virus replication |
| 01/30/1997 | WO1997003094A1 Cell adhesion inhibitors |
| 01/30/1997 | WO1997003076A1 Heterocycle-fused thiazole derivatives |
| 01/30/1997 | WO1997003074A1 4-amino-3-acylnaphthyridine derivatives |
| 01/30/1997 | WO1997003066A1 Substituted benzolactam compounds as substance p antagonists |
| 01/30/1997 | WO1997002835A1 Intranasal vaccination against gastrointestinal disease |
| 01/30/1997 | WO1997002833A1 A stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least, one basic amino acid residue and at least one acid amino acid residue |
| 01/30/1997 | WO1997002832A1 Lyophilized hgf preparations |
| 01/30/1997 | WO1997002829A2 Use of indigestible oligosaccharides to prevent and treat diarrhea |
| 01/30/1997 | WO1997002730A2 Enamel matrix related polypeptide |
| 01/30/1997 | WO1996035805A3 Tripeptidylpeptidase inhibitors |
| 01/30/1997 | WO1996030016A3 Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases |
| 01/30/1997 | CA2226868A1 Cell adhesion inhibitors |
| 01/30/1997 | CA2226570A1 Enamel matrix related polypeptide |
| 01/30/1997 | CA2226553A1 A stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least, one basic amino acid residue and at least one acid amino acid residue |
| 01/30/1997 | CA2226392A1 Intranasal vaccination against gastrointestinal disease |
| 01/30/1997 | CA2223645A1 Antisense inhibition of hepatitis b virus replication |
| 01/29/1997 | EP0755404A1 Tachykinin antagonists |
| 01/29/1997 | EP0755394A1 A method of inducing cholecystokinin agonist activity using 1,4-benzodiazepine compounds |
| 01/29/1997 | EP0755384A1 Cck or gastrin modulating 1,5 benzodiazepines derivatives |
| 01/29/1997 | EP0755380A1 15-deoxyspergualin analogs, therapeutical use thereof, and method for preparing same |
| 01/29/1997 | EP0755251A1 Low dosage ranitidine compositions for the treatment of minor gastrointestinal disorders associated with excess acid secretion |
| 01/29/1997 | CN1141637A Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/29/1997 | CN1141593A Medical apptication of bromelain |
| 01/29/1997 | CN1141589A Film coated tablet of paracetamol and domperidone |
| 01/28/1997 | US5597832 Tetracyclic compounds as dopamine agonists |
| 01/28/1997 | US5597826 Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist |
| 01/28/1997 | US5597552 Dentinal desensitizing compositions |
| 01/23/1997 | WO1997002342A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
| 01/23/1997 | WO1997002287A1 Parevins and tachytegrins |
| 01/23/1997 | WO1997002254A1 Quinazoline derivatives |
| 01/23/1997 | WO1997002248A1 Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use |
| 01/23/1997 | WO1997002244A1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 01/23/1997 | WO1997002039A1 Antibacterial synergistic composition comprising rifabutin |
| 01/23/1997 | WO1997002026A1 Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases |
| 01/23/1997 | WO1997002020A1 Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole |
| 01/23/1997 | WO1996040168A3 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 01/23/1997 | CA2587000A1 Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole |
| 01/23/1997 | CA2226121A1 Parevins and tachytegrins |
| 01/22/1997 | EP0754688A2 Dioxolane intermediates |
| 01/22/1997 | EP0754687A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/22/1997 | EP0754466A2 Osteoinduction substance, method of manufacturing the same, and bone filling material including the same |
| 01/22/1997 | EP0754228A1 $g(a)-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY |
| 01/22/1997 | EP0754189A1 Receptor modulating agents and methods relating thereto |
| 01/22/1997 | EP0754061A1 New oral pharmaceutical dosage form |
| 01/22/1997 | EP0754053A1 Novel hemostatic composition |
| 01/22/1997 | EP0754037A1 Methods of administering n-substituted benzamides or phenothiazines |
| 01/22/1997 | EP0615450B1 Dimeticon pastilles |
| 01/22/1997 | CN1141059A P53-binding polypeptides and polynucleotides encoding same |
| 01/22/1997 | CN1141043A Non-peptide tachykinin receptor antagonists |
| 01/22/1997 | CN1140998A Compositions which inhibit apoptosis, method of purifying the compositions and uses thereof |
| 01/22/1997 | CN1140996A Ranitidine and calcium carbonate pharmaceutical combination product |
| 01/22/1997 | CN1140588A "Shuganmei" medicine for treatment of liver disease and its preparation |
| 01/22/1997 | CN1033865C Cell-associated glucosyltransferase, antibody thereto, and dental caries prophylactic composition contg. said antibody as effective component |
| 01/21/1997 | US5596101 N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them |
| 01/21/1997 | US5596009 Fused benzeneoxyacetic acid derivatives |
| 01/21/1997 | US5595989 Antiinflammatory agents and antidiabetic agents |
| 01/21/1997 | US5595868 Monoclonal antibodies to hepatitis C virus |
| 01/21/1997 | CA2100918C Oxime derivative |
| 01/16/1997 | WO1997001640A2 Vaccines against hepatitis c |
| 01/16/1997 | WO1997001553A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 01/16/1997 | WO1997001354A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 01/16/1997 | WO1997001353A1 Use of il-11 to treat inflammation |
| 01/16/1997 | WO1997001335A1 Di- and trivalent small molecule selectin inhibitors |
| 01/16/1997 | CA2224516A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 01/16/1997 | CA2222456A1 Vaccines against hepatitis c |
| 01/16/1997 | CA2222024A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 01/16/1997 | CA2220554A1 Use of il-11 to treat inflammation |
| 01/15/1997 | EP0753062A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 01/15/1997 | EP0753004A1 Antagonists of endothelin receptors |
| 01/15/1997 | EP0752991A1 INDENO[1,2-e]PYRAZINE-4-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 01/15/1997 | EP0752986A1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists |
| 01/15/1997 | EP0752886A1 Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
| 01/15/1997 | EP0752863A1 Use of biopolymers for digestive tract injuries treatment |
| 01/15/1997 | EP0752851A1 New pharmaceutical formulation and process |
| 01/15/1997 | EP0752849A1 Heme-bearing microparticles for targeted delivery of drugs |
| 01/15/1997 | CN1140454A Novel mercaptoacetylamido-1,3,4,5-tetrahydro-benzo|c¨ azepin-3-one disulfide derivs. useful as inhibitors of enkephalinase and ACE |
| 01/15/1997 | CN1140451A Novel indane-2-mercaptoacetylamide disulfide derivs. useful as inhibitors of enkephalinase |
| 01/15/1997 | CN1140174A Piperidine derivatives, process for preparation thereof and application thereof in therapeutics |
| 01/15/1997 | CN1140167A Process for preparing substituted 2-amino tetrahydronaphthalenes and 3-aminochromanes |
| 01/15/1997 | CN1140165A Arylsulfonyl hydroxamic acid derivatives |
| 01/15/1997 | CN1140078A Formula and producing process for fainting-relieving tablet |
| 01/14/1997 | US5594023 1,3-dihydroindol-2-one derivatives substituted in the 3-position by a nitrogen-containing group, their preparation and the pharmaceutical compositions in which they are present |
| 01/14/1997 | US5594022 Carbamates |
| 01/14/1997 | US5594019 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles |
| 01/14/1997 | US5594014 Indole derivatives as 5-HT1 agonists |
| 01/14/1997 | US5593992 Cytokine inhibitors |
| 01/14/1997 | US5593991 Imidazole compounds, use and process of making |
| 01/14/1997 | US5593990 Methods and compositions for inhibition of angiogenesis |